ICON PLCICLREarnings & Financial Report

Nasdaq · pharmaceutical industry

ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.

NextMar 13, 2026

Revenue

$2.0B

Gross Profit

N/A

Operating Profit

$86.6M

Net Profit

$2.4M

Gross Margin

N/A

Operating Margin

4.2%

Net Margin

0.1%

YoY Growth

0.6%

EPS

$0.03

Financial Flow

ICON PLC Q3 2025 Financial Summary

ICON PLC reported revenue of $2.0B for Q3 2025, with a net profit of $2.4M (0.1% margin). Cost of goods sold was N/A, operating expenses totaled N/A.

Key Financial Metrics

Total Revenue	$2.0B
Net Profit	$2.4M
Gross Margin	N/A
Operating Margin	4.2%
Report Period	Q3 2025

Income Statement

	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Revenue	$2.02B	$2.06B	$2.09B	$2.12B	$2.03B	$2.00B	$2.02B	$2.04B
YoY Growth	4.4%	5.8%	5.7%	4.9%	-1.2%	-4.3%	-4.8%	0.6%

Balance Sheet

	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Assets	$17.11B	$17.03B	$17.05B	$16.97B	$17.21B	$16.72B	$16.60B	$16.51B
Liabilities	$8.31B	$8.07B	$7.62B	$7.38B	$7.44B	$7.22B	$7.05B	$7.17B
Equity	$8.80B	$8.96B	$9.43B	$9.59B	$9.77B	$9.50B	$9.56B	$9.33B